Höglund, K
Kern, S
Zettergren, A
Börjesson-Hansson, A
Zetterberg, H
Skoog, I
Blennow, K
Article History
Received: 10 March 2016
Revised: 1 June 2016
Accepted: 30 June 2016
First Online: 10 January 2017
Competing interests
: KB and HZ are co-founders of Brain Biomarker Solutions in Gothenburg AB, a GU Venture-based platform company at the University of Gothenburg. KB has served as a consultant for Eli Lilly, Novartis, Roche Diagnostics, and Sanofi-Aventis and at Advisory Boards for Amgen and IBL International, and given lectures for Fujirebio Europe and Lundbeck. KB’s research team has received grants for collaborative research projects from Eli Lilly and Roche Diagnostics. KH, AZ, SK, IS and AB have nothing to disclose. As primary authors, KH and SK have had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.